SCHEMBL22411468

SCHEMBL22411468

COc1ccc(CNc2nc(Cl)nc3c(I)c[nH]c23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE2 O96020 1/20 0.52
CCNE1 P24864 1/20 0.52
CDK2 P24941 1/20 0.52
MAPT P10636 3/20 0.49
CDK1 P06493 3/20 0.45
HTT P42858 1/20 0.43
PRUNE1 Q86TP1 1/20 0.41
NPC1 O15118 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPK1 P28482 1/20 0.41
OXTR P30559 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PIK3CA P42336 1/20 0.40
CCNB2 O95067 2/20 0.40
CCNB1 P14635 2/20 0.40
CCNB3 Q8WWL7 2/20 0.40
PDE5A O76074 1/20 0.40
POLB P06746 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22411496 0.81 CDK2 (0.47) CCNE2CCNE1CDK2MAPTCDK1
SCHEMBL15619030 0.81 CCNE2 (0.68) CCNE2CCNE1CDK2MAPTCDK1
SCHEMBL22411474 0.77 MAPT (0.52) CCNE2CCNE1CDK2MAPTHTT
SCHEMBL5827851 0.76 MAPT (0.78) CCNE2CCNE1CDK2MAPTCDK1
SCHEMBL29133952 0.75 CCNE2 (0.55) CCNE2CCNE1CDK2MAPTCDK1
SCHEMBL30661275 0.75 CCNE2 (0.55) CCNE2CCNE1CDK2MAPTCDK1
SCHEMBL3108534 0.75 CCNE2 (0.61) CCNE2CCNE1CDK2MAPTCDK1
SCHEMBL21332784 0.74 CCNE2 (0.51) CCNE2CCNE1CDK2MAPTCDK1
SCHEMBL3114875 0.72 CCNE2 (0.55) CCNE2CCNE1CDK2MAPTHTT
SCHEMBL3108353 0.71 CCNE2 (0.54) CCNE2CCNE1CDK2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220144838-A1 Compounds as Inhibitors of Macrophage Migration Inhibitory Factor Nanjing Immunophage Biotech Co., Ltd. (CN) 2022-05-12 US disclosed
US-20220144838-A1 Compounds as Inhibitors of Macrophage Migration Inhibitory Factor Nanjing Immunophage Biotech Co., Ltd. (CN) 2022-05-12 US disclosed
WO-2020186220-A1 COMPOUNDS AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR IMMUNOPHAGE BIOMEDICAL CO., LTD. (CN) 2020-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144838-A1 Compounds as Inhibitors of Macrophage Migration Inhibitory Factor MIF, MMP12, SLC11A2 CCNE2 3759/4885CCNE1 3696/4885CDK2 2139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.